Elon Musk has entered a civil trial against OpenAI and CEO Sam Altman in a San Francisco federal court [1].

The outcome of the case could redefine the legal obligations of artificial intelligence companies that transition from non-profit foundations to commercial enterprises. It also pits the world's richest person [2] against the leader of the most prominent AI laboratory in the U.S. [1].

The trial began on May 12 [3] at the U.S. District Court for the Northern District of California [4]. Musk, a founder of Tesla and xAI and a co-founder of OpenAI, alleges that Altman stole a charitable fund and violated the company's founding principles [1].

According to the lawsuit, Musk argues that OpenAI was steered toward a "get-rich-quick" profit model [5]. This shift, Musk said, breached the original non-profit mission of the organization. As part of the legal action, Musk is seeking the removal of Altman from leadership [5].

Court proceedings included opening statements on May 12 and testimony on May 13 [3]. The case involves other key figures, including OpenAI co-founder Greg Brockman [1].

While some reports indicate the trial is in its early stages with opening statements [5], other accounts suggest the proceedings have moved toward closing arguments and jury deliberations [1]. The core of the dispute remains the alleged betrayal of the charitable goals that initially defined OpenAI's structure [5].

Musk's legal team is focusing on the transition of the company's governance and the alleged misuse of funds intended for the public good [1]. Altman and OpenAI have defended their current structure as necessary for the scale of compute, and capital required to develop advanced AI [5].

“Musk claims Altman stole a charitable fund and breached OpenAI’s original non-profit mission.”

This trial serves as a litmus test for the governance of AI companies. If the court finds that OpenAI breached its original non-profit charter, it could set a precedent requiring AI firms to maintain strict transparency or altruistic constraints, potentially hindering the aggressive commercialization of the technology.